ABSTRACT
MALIGNANCY11 Cancer represents a major cause of morbidity and mortality for renal transplant recipients. In Europe, the overall prevalence of cancer after renal transplantation is between 20 and 30% at 10 years, and can reach 40% at 20 years (Berhoux et al., 2002). In the USA, the adjusted death rate from cancer for renal transplant patients is 1.4 per 1000 person-years (Ojo et al., 2000). In Australia and New Zealand, the cumulative risk of tumors other than those of the skin is 40% by 30 years after transplantation, whereas 75% of renal allograft recipients have skin cancer (Sheil, 2002).
